ClinicalTrials.gg
RecruitingNCT06701006ISSPUpdated Nov 13, 2026

Integrated Suicide Supports and Safety Planning for Youth

An interventional study of Integrated skills and safety planning app in Suicidal Ideation and Suicidal Behavior, sponsored by University of Washington. Recruiting at 1 site in United States. Open to participants aged 13 Years to 21 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by University of Washington · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.
Updated Nov 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
13 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 11 studies in Suicidal Ideation by University of Washington — 3 open to participants now, 4 under way, none of them phase 3. Suicidal Ideation · University of Washington.

Planned enrollment
6th of 11
60 · median 60
Started
2025
with 2 others
No phase
9 of 11
3 open now
Registered
9th of 11
by date

Among the 11 studies in Suicidal Ideation by University of Washington, this one is the 6th largest by planned enrollment, is one of 3 that started in 2025, is one of 9 with no phase, and was the 9th registered.

Suicidal Ideation

570 studies on the registry are indexed under Suicidal Ideation; 204 are open to participants now.

Browse Suicidal Ideation studies →

Open to participants now

3 of the 11 studies in Suicidal Ideation by University of Washington are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 135 Suicidal Ideation studies recruiting now, 52 (39%) set no upper age limit and 79 (59%) stop at 75 or younger; 54 take children under 18; 32 take healthy volunteers.

This study: 13 Years to 21 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Suicidal Ideation by University of Washington, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate an app to help keep teens and young adults with suicidal thoughts safe. The app includes a safety plan created by adolescents and healthcare providers, and videos to encourage supportive communication and skills for teens and young adults to stay safe. The main question it aims to answer is whether the use of an app can increase youth suicide-related coping for youth with suicidal ideation, parent/caregiver suicide prevention self-efficacy, and healthcare provider self-efficacy in suicide management. Researchers will compare usual care to usual care with the app. Participants, including adolescents, caregivers, and healthcare providers, will use the ISSP app (if assigned to that group) and view video content and complete three online surveys.

Read the detailed description

The current study aims to evaluate the Jaspr app relative to usual care among youth (ages 13-21 years) who indicate suicidal ideation in pediatric medical settings. The Jaspr app includes supported safety planning between the young person and the healthcare provider, as well as skills and support videos for youth and caregivers intended to increase coping and decrease distress with an opportunity to access these resources through an at home app. Adolescents, parents, and clinicians will participate in the project to assess the effectiveness of Jaspr augmenting usual care, compared to usual care alone. The study will use a pre-post design in which each setting begins with a control period and then transitions to the addition of Jaspr following healthcare provider training on use of the app. Participants and their parents/caregivers will receive study assessments at baseline, 1-month, and 2-month follow up timepoints, and healthcare providers complete a survey at baseline, and the end of each period (control and intervention). Study assessments with youth will ask about coping, suicidal ideation and severity, anxiety and depression, service utilization, functional impairment, access to lethal means, and acceptability of the app. Study assessments for parents/caregivers will ask about their self-efficacy in managing their youth's suicidality, acceptability of the videos/app, and service utilization for the youth. Healthcare providers will complete surveys assessing their self-efficacy in managing youth suicidality and feasibility of use of the app. Youth, their legal guardian, and healthcare providers each assent/consent to participate in the research procedures.

03

Conditions studied

  • Suicidal Ideation
  • Suicidal Behavior

Keywords

  • adolescents
  • young adults
  • suicide prevention
  • health services research
04

Who can participate

Ages eligible
13 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Youth Inclusion Criteria:

  • Age 13 -21 years, an Ask Suicide Questions (ASQ) screen score of 1-5 with active ideation (not solely a history of a prior attempt) but no current plan or intent, or patient-reported suicidal thoughts and behaviors during a clinical assessment in a medical setting who are judged by a clinician to be appropriate for conducting higher level assessment in that setting (including a BSSA and/or safety planning) in order to support care at home.
  • Parents/guardians: One "parent" per AYA will also be invited to participate.
  • HCPs: All HCPs in participating settings who may conduct assessments of SI and safety planning (physicians, nurse practitioners/physician's assistants, social workers, mental health counselors, psychologists) will be invited to participate.
  • All subjects must have access to the internet and a computer or tablet device.

Youth Exclusion Criteria:

  • Concurrently enrolled in an affiliated Suicide Care Research Center study, no phone access, or non-English speaking.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Usual Care
  • Experimental
    Integrated skills and safety planning app

    Use of Jaspr app for clinical care + at home

    Other: Integrated skills and safety planning app

Interventions

  • OtherIntegrated skills and safety planning app

    This is a digital app that includes supported safety planning resources in medical settings as well as coping skills and lived experience videos for adolescents, young adults and parents/caregivers that can be accessed while in the medical setting or at home.

    Also known as: Jaspr

06

What researchers measure

Primary outcomes

  1. Youth Suicide-Related Coping

    Total Score on the 17-item Youth Suicide-Related Coping Scale

    Time frame: Baseline, 1 month, 2 month

  2. Parent suicide prevention self-efficacy

    Total score on the Parent suicide prevention self-efficacy scale

    Time frame: Baseline, 1 month, 2 month

  3. Healthcare provider self-efficacy in suicide management

    Total score on the Provider suicide Intervention Questionnaire

    Time frame: Baseline, end of control period, and end of intervention period

Secondary outcomes

  1. Safety Plan Quality

    Safety Planning Scoring Algorithm (SPISA) based on youth medical chart review

    Time frame: Up to 1 month

  2. Youth Suicide Severity

    Total score on the online self-report version of the Columbia Suicide Severity Rating Scale (C-SSRS)

    Time frame: Baseline, 1 month, 2 month

  3. Youth Anxiety Symptoms

    Total Score on Youth Self-Reported Generalized Anxiety Disorder -7 item scale

    Time frame: Baseline, 1 month, 2 month

  4. Intervention Acceptability

    Youth and Parent Report on the Acceptability of Intervention Measure (AIM)

    Time frame: Baseline, 1 month, 2 month

  5. Functional Impairment

    Total score on the youth reported EQ-5D-Y quality of life measure

    Time frame: Baseline, 1 month, 2 month

  6. Youth Suicidal ideation

    Total Score on the Harkavy Asnis Suicide Scale ideation subscale (HASS-I),

    Time frame: Baseline, 1 month, 2 month

  7. Youth Depressive Symptoms

    Total score on the Patient Health Questionnaire 9

    Time frame: Baseline, 1 month, 2 month

Other outcomes

  1. Access to Lethal Means

    BRFSS Module 17 - Youth report of access to a firearm

    Time frame: 1 month

  2. Intervention Feasibility

    Healthcare Provider Report on the Feasibility of Intervention Measure (FIM)

    Time frame: Baseline, 1 month, 2 month

  3. Mental Health Services Use

    Dichotomous rating of any mental health service use following baseline using chart review or indication based on parent or youth report on the Services Assessment for Children and Adolescents (SACA)

    Time frame: Baseline, 2 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — We plan to share required elements with the NIMH NDA.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.

Of 282 non-industry interventional studies with no phase under Suicidal Ideation, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 15 months is below that.

Counting every sponsor, half of 291 studies reached it within 30 months; a quarter within 13 and three quarters within 54.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Nov 2026 → Dec 2026 and completion Nov 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2024
First posted
Nov 22, 2024
StartActual
Aug 19, 2025
Primary completionEst.
Dec 1, 2026was Nov 2026
CompletionEst.
Dec 1, 2026was Nov 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Nov 1, 2026→Dec 1, 2026
Nov 13, 2026
Study completion
Nov 1, 2026→Dec 1, 2026
Nov 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Seattle Children's Hospital · Seattle, United StatesContact A•••@seattlechildrens.org · •••1895→j•••@seattlechildrens.org · •••7484
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Primary completion Nov 1, 2026→Dec 1, 2026
    Study completion Nov 1, 2026→Dec 1, 2026
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Seattle Children's Hospital · Seattle, United StatesContact A•••@seattlechildrens.org · •••1895→j•••@seattlechildrens.org · •••7484

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06701006
Responsible party
Laura Richardson (Professor of Pediatrics, University of Washington) — Principal investigator
First posted
Nov 22, 2024
Start date
Aug 19, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Nov 13, 2026

Study contacts

Laura Richardson, MD, MPH
Contact
lpr@uw.edu
206-987-2028
Laura Richardson, MD, MPH
principal investigator · University of Washington

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion